← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2011Last known activity
May 5, 2025
Timeline
1990s
- Jun 1, 1998
Amarex Clinical Research— Founded
Drugs by trial phase (23 distinct, 29 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (15 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Studied for
- Basal Cell Carcinoma
- Bowen's Disease
- Breast Neoplasms
- Burns
- Carcinoma
- Carcinoma in Situ
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Cervical Intraepithelial Neoplasia
- Coronavirus Infections
- Dermatitis
- Dermatitis, Atopic
- Eczema
- Fatty Liver
- Graft vs Host Disease
- Lymphopenia
- Neoplasms
- Non-alcoholic Fatty Liver Disease
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Papillomavirus Infections
- Progeria
- Schizophrenia
- Spinal Cord Injuries
- Syndrome
- Triple Negative Breast Neoplasms
- Ulcer
- Uterine Cervical Dysplasia
- Werner Syndrome
Recent trials (31)
- NCT06828666CollaboratorPhase 1/Phase 2May 5, 2025
- NCT05592418CollaboratorPhase 2Mar 31, 2023
- NCT05555862CollaboratorPhase 2Nov 15, 2022
- NCT05571969CollaboratorPhase 1Oct 20, 2022
- NCT05494697CollaboratorPhase 2Sep 30, 2022
- NCT05730673CollaboratorPhase 2Sep 20, 2022
- NCT05844787CollaboratorPhase 1Jul 11, 2022
- NCT04678830CollaboratorPhase 2Jan 21, 2021
- NCT04669808CollaboratorPhase 2Dec 16, 2020
- NCT04521114CollaboratorPhase 2Oct 1, 2020
- NCT04442178CollaboratorPhase 2Sep 15, 2020
- NCT04512963CollaboratorPhase 1Aug 24, 2020
- NCT04426201CollaboratorPhase 2Jun 22, 2020
- NCT04407689CollaboratorPhase 2Jun 1, 2020
- NCT04379076CollaboratorPhase 2May 14, 2020
Details
- Founded
- Germantown, MD, US Jun 1, 1998
- Last known activity
- May 5, 2025
Notes
CRO